Lowering Health Care Costs for All Americans: An Examination of the Prescription Drug Supply Chain

House 119th · February 11, 2026 at 3:15 PM
Rayburn House Office Building, Room 2123 · Scheduled
Energy and Commerce Committee › Health Subcommittee · 30 members ↓
Griffith, H. Morgan R-VA Chair
Harshbarger, Diana R-TN Vice Chair
Carter, Earl L. "Buddy" R-GA
Rulli, Michael A. R-OH
Langworthy, Nicholas A. R-NY
Bentz, Cliff R-OR
Crenshaw, Dan R-TX
Houchin, Erin R-IN
Kean, Thomas H. R-NJ
Obernolte, Jay R-CA
James, John R-MI
Joyce, John R-PA
Cammack, Kat R-FL
Bilirakis, Gus M. R-FL
Miller-Meeks, Mariannette R-IA
Dunn, Neal P. R-FL
Balderson, Troy R-OH
DeGette, Diana D-CO Ranking
Carter, Troy A. D-LA
Veasey, Marc A. D-TX
Ocasio-Cortez, Alexandria D-NY
Dingell, Debbie D-MI
Barragán, Nanette Diaz D-CA
Landsman, Greg D-OH
Auchincloss, Jake D-MA
Schrier, Kim D-WA
Kelly, Robin L. D-IL
Fletcher, Lizzie D-TX
Trahan, Lori D-MA
Ruiz, Raul D-CA
Witnesses (9) Show all +
John Murphy
President and CEO
Association for Accessible Medicines
Rachel E. Sachs
Professor of Law
Washington University in St. Louis
Lori Reilly, Esq.
Chief Operating Officer
PhRMA
John Crowley
President and CEO
Biotechnology Innovation Organization
David Marin
President and CEO
Pharmaceutical Care Management Association
Angie Boliver
President and CEO
Healthcare Supply Chain Association
Chester “Chip” Davis, Jr.
President and CEO
Healthcare Distribution Alliance
James Gelfand
President and CEO
The ERISA Industry Committee
B. Douglas Hoey
Chief Executive Officer
National Community Pharmacists Association

Free access to AI-generated transcripts

Speaker identification, synchronized video playback, full-text search, and deep linking — all free.

Create Free Account
Browse hearings with transcripts